ABSTRACT. Several drugs that interact with membrane sterols or inhibit their syntheses are effective in clearing a number of fungal infections. The AIDS-associated lung infection caused by Pneumocystis jirovecii is not cleared by many of these therapies. Pneumocystis normally synthesizes distinct C 28 and C 29 24-alkylsterols, but ergosterol, the major fungal sterol, is not among them. Two distinct sterol compositional phenotypes were previously observed in P. jirovecii. One was characterized by ⌬ 7 C 28 and C 29 24-alkylsterols with only low proportions of higher molecular mass components. In contrast, the other type was dominated by high C 31 and C 32 24-alkylsterols, especially pneumocysterol. In the present study, 28 molecular species were elucidated by nuclear magnetic resonance analysis of a human lung specimen containing P. jirovecii representing the latter sterol profile phenotype. Fifteen of the 28 had the methyl group at C-14 of the sterol nucleus and these represented 96% of the total sterol mass in the specimen (excluding cholesterol). These results strongly suggest that sterol 14␣-demethylase was blocked in these organisms. Twenty-four of the 28 were 24-alkylsterols, indicating that methylation of the C-24 position of the sterol side chain by S-adenosyl-L-methionine:sterol C-24 methyl transferase was fully functional.
P
NEUMOCYSTIS pneumonia (PcP) remains among the most prevalent opportunistic infections in immunocompromised individuals, such as AIDS patients. Preventing the onset of AIDS by Highly Active Antiretroviral Therapy (HAART) among HIV-infected people and aggressive prophylaxis and treatment of PcP have successfully reduced the number of deaths directly attributed to Pneumocystis. However, AIDS patients and others with prolonged immunodeficiency experience recurrent P. jirovecii infections. Also, some patients cannot tolerate some anti-PcP drugs, such as trimethoprim/sulfamethoxazole (TMP/SMZ) (Hughes 1998; Simonds et al. 1995) , and there is evidence for drug-resistant pathogen populations (Costa et al. 2001; Ma et al. 1999; Walker et al. 1998) . Thus, PcP remains of significant concern for those with defective immune systems.
Reactions in Pneumocystis sterol biosynthesis are currently receiving increased attention as attractive targets for developing new chemotherapeutic approaches against PcP. Treatment of rat-derived P. carinii by a number of sterol biosynthesis inhibitor compounds reduced viability (cellular ATP) in vitro . Recently, a number of oxidosqualene cyclase inhibitors were tested and shown to have detrimental effects on P. carinii growth in vitro (Hinshaw et al. 2003) . Inhibition of the enzyme S-adenosyl-L-methionine:sterol C-24 methyl transferase (SAM:SMT) also reduced P. carinii proliferation in vitro (Urbina et al. 1997) . Terbinafine, which targets squalene epoxidase, reduced P. carinii infections in vivo in rats (Contini et al. 1996) . Since there is yet no culture method for rapid and luxuriant growth of Pneumocystis organisms, molecular biology approaches are being used to study sterol biosynthesis in this unusual fungus. Hence, several P. carinii genes that code for sterol synthesis enzymes have now been cloned, sequenced, and expressed in heterologous systems, namely the erg6 gene encoding SAM:SMT Kaneshiro et al. 2002) , the erg7 gene encoding oxidosqualene cyclase (Milla et al. 2002) , and the erg11 gene encoding sterol 14␣-demethylase (Morales et al. 2003) .
A comprehensive study of sterols from P. carinii isolated from corticosteroid-immunosuppresssed rats has been performed, and definitive structures of 43 molecular species were elucidated by nuclear magnetic resonance spectroscopy (NMR) . ␦ 7 desmethyl sterols comprised approximately 44% of the total by mass (excluding cholesterol) and a total of only 7% had methyl groups at C-4 and/or C-14 of the sterol nucleus. Pneumocystis species from other mammalian species appear to have similar sterol compositions in that only low proportions of C 31 and C 32 sterols were detected (Amit 1998) . Studies on Pneumocystis jirovecii that infect humans are even more difficult to perform due to the lack of available samples and especially specimens with sufficient organisms for direct analyses. Thus, only limited biochemical data on P. jirovecii are currently available in the literature. Although these include some studies on sterols (Amit and Kaneshiro 2001; Chandra et al. 1999; Kaneshiro and Wyder 2000; Kaneshiro et al. 1999a,b; Kaneshiro et al. 1996) ; there is no comprehensive report on the definitive structural identification of most sterol components detected in P. jirovecii. In the previous reports, the P. jirovecii sterols were tentatively identified by gas-liquid chromatography (GLC). Mass spectrometry (MS) was performed on only a few components. Aside from the C 32 sterol pneumocysterol (24Z-ethylidenelanost-8-en-3␤-ol) and C 31 24-methylenelanost-8-en-3␤-ol (Kaneshiro et al. 1999b) , structural identities including stereochemical properties are lacking for the rest of the sterol molecules in human-derived specimens. It was earlier noted that the GLC sterol compositions of some P. jirovecii specimens were dramatically different from some other specimens and the striking feature was the abundance of higher molecular mass, late-eluting components (Amit and Kaneshiro 2001; Kaneshiro et al. 1999b) . Pneumocysterol was present in only trace or low amounts in some P. jirovecii specimens, similar to that observed in rat-derived P. carinii and Pneumocystis in some other mammalian host species (Amit 1998) . In contrast, pneumocysterol comprised over 50% of the non-cholesterol sterols in some other P. jirovecii samples. Biochemical compositions of human-derived material are expected to exhibit broader variations than those from laboratory animals kept under controlled conditions. However, the broad range of P. jirovecii sterol compositions observed suggested the existence of two phenotypically distinct P. jirovecii populations; compositions that were intermediates between the extremes might then represent mixed infections of the two types in various proportions (Amit and Kaneshiro 2001; Kaneshiro et al. 1999a) . This difference in P. jirovecii sterol composition was not correlated with the persons' HIV/AIDS status, geographic location, or drug therapy. Further support for two distinct P. jirovecii populations came from finding a broad range in the proportions of the sterols in samples taken from different sites in the same pair of infected human lungs (Amit and Kaneshiro 2001) . That study eliminated human host factors as the basis for these differences. The existence of distinct strains of P. jirovecii has been documented by analysis of several gene loci (Hauser et al. 2001; Helweg-Larsen et al 2001; Stringer et al. 2002) other than those that code for sterol biosynthesis enzymes.
The general structural features of the P. jirovecii sterols suggested that the populations with sterol compositions dominated by the higher molecular mass sterols might be explained by low sterol 14␣-demethylase activity in these organisms (Kaneshiro et al. 1999a ). However, definitive structural identities by NMR were not obtained at that time. NMR generally requires larger sample sizes compared to the highly sensitive GLC and MS techniques. We recently were able to prepare a sample of P. jirovecii sterols from a human lung specimen containing high proportions of pneumocysterol. This sample provided sufficient material for 600 MHz NMR studies that allowed comprehensive analyses and definitive structural identities of the sterols in this P. jirovecii population.
MATERIALS AND METHODS

Specimens.
Preparations of Pneumocystis jirovecii that contained low proportions of C 30 -C 32 sterols were generously provided by Bettina Lundgren (Hvidovre Hospital, Copenhagen, Denmark). Organisms were isolated from a cryopreserved human lung obtained from a HIV-negative non-Hodgkin lymphoma patient who had been treated with trimethoprim plus sulfamethoxazole (TMP/SMZ, Bactrim) and steroid (prednisolone). This specimen was originally coded Pch 1/97 and was also designated Denmark-1 (Kaneshiro et al. 1999a ). The organisms were purified by Percoll gradient centrifugation. Another P. jirovecii preparation (designated Denmark-4, Kaneshiro et al. 1999a ) with low levels of C 30 -C 32 sterols was from an AIDS patient who was treated with trimethoprim plus sulfamethoxazole (TMP/SMZ), pentamidine, and steroid. Organisms from this cryopreserved lung were partially purified by differential centrifugation.
A sample containing high proportions of C 30 -C 32 sterols was from a cryopreserved PcP lung from an AIDS patient. Organisms were partially purified by differential centrifugation and kindly provided by Carlo Contini (University of Ferrara, Italy). The patient, coded Italy-1 (Kaneshiro et al. 1999a) received no treatment for the infection. The above isolated P. jirovecii organisms from cryopreserved lungs were analyzed by GLC.
Another sample that contained high levels of C 30 -C 32 sterols was from a formalin-fixed pair of lungs from a male AIDS victim who died of PcP but received no treatment for the infection (Mercio Perreira, Tufts Medical School, Boston, pers. commun.) (Amit and Kaneshiro 2001; Kaneshiro et al. 1999a, b; Kaneshiro et al. 1996) . This lung provided sufficient material for GLC, MS, and NMR spectroscopy analyses.
Eleven other formalin-fixed autopsied normal human lungs were analyzed by GLC as controls. The lungs were P. jiroveciinegative as determined by light microscopy. All formalin-fixed lungs were homogenized with distilled water in a stainless steel blender for 2 min.
Extraction of lipids and isolation of sterols. Total lipids were extracted using chloroform:methanol:water (1:2:0.75, v/v/ v) (Bligh and Dyer 1959) at room temperature for 2 h, and purified by biphasic partitioning (Folch et al. 1957) . Total extracted lipids were fractionated by adsorption column chromatography (Unisil, Williamsport, PA); the neutral lipid fraction was obtained by elution with chloroform. Free sterols were isolated from the neutral lipid fraction by thin-layer chromatography (TLC) developed in petroleum ether: diethyl ether:acetic acid (80:20:1, v/v/v) . Alternatively, GLC analysis was performed on the total sterols obtained by saponification of the neutral lipid fraction (15% KOH in methanol; 65 ЊC, 30 min), water added, and the total non-saponifiable fraction was extracted into petroleum ether (Kaneshiro et al. 1999a) .
GLC analysis. Sterols were dissolved in hexane and analyzed by GLC as previously described (Kaneshiro et al. 1999a; Kaneshiro et al. 1994) . Chromatography was performed in either a Hewlett-Packard 5890 or 6890 Series II GLC equipped with a 3 m ϫ 0.32 mm i.d. capillary column (DB-5 or SPB-5). Isothermal analyses were performed using an oven temperature of 250 ЊC; injection and flame ionization detector temperatures were set at 280 ЊC and 305 ЊC, respectively. The carrier gas was helium at a flow rate of 1 ml/min. Relative retention times (RRT) were calculated using the retention time of cholesterol as reference (RRT chol ).
Separation and purification of sterols for NMR analysis. Free sterols were fractionated by preparative TLC using plates coated with Silica Gel 60 F254 (0.25-mm thick) and using the solvent system hexane:ethyl acetate (4:1, v/v) containing 0.5% 2,3-dimethyl-2-butene as an antioxidant. This sample, containing 54 mg of sterols, was fractionated into 4,4-dimethyl sterols, 4␣-methyl sterols, and desmethylsterols. Since the 4,4-dimethyl fraction and desmethylsterol fraction had such high concentrations of pneumocysterol and cholesterol, respectively, these major sterols were first removed from the other sterols by reversed phase HPLC and argentation TLC. HPLC separations were performed using two Altex Ultrasphere 5-m ODS columns (10 mm ϫ 250 mm) in series employing a Waters 4000A pump and Waters 410 differential refractometer. The first separation was carried out using methanol as the elution solvent (solvent system A). The fractions containing cholesterol and pneumocysterol were further purified by HPLC using the solvent system acetonitrile:methanol:ethyl acetate (11:4:4, v/v/v; solvent system B). The cholesterol fraction obtained after the second round of HPLC purification was converted into the acetate esters by treatment with acetyl anhydride/pyridine, and then purified by argentation TLC. The argentation TLC plates were prepared by wetting 0.25 mm-thick Silica Gel TLC plates with a saturated solution of AgNO 3 in methanol, followed by drying. Hexane:ethyl acetate (4:1, v/v) was used as the solvent system. Cholesterol acetate was recovered from the plates and the minor sterol esters were saponified to convert them back into free sterols using 10% KOH in ethanol at room temperature for 2 h.
After removal of the cholesterol and pneumocysterol, each of the three fractions of sterol components was then subjected to HPLC using solvent system A as described above. The desmethylsterol fraction was subjected to another round of HPLC fractionation using solvent system B to separate the remaining cholesterol from the other components in the fraction. Purified HPLC fractions containing individual sterols were dried under a stream of N 2 prior to NMR and MS analysis.
NMR and MS analyses. The sterols were analyzed by highfield 1 H-NMR; spectra were acquired using a Bruker Avance-600 MHz instrument using CDCl 3 as the solvent and referenced to residual CHCl 3 signals ( 1 H: 7.26 ppm). The structures were assigned by comparison with NMR spectra of authentic standards. The assignments of structures for novel sterols were based on both NMR and MS spectra. The MS was performed on a Hewlett-Packard 5989B MS operating at 70 eV in the electron impact mode. Structural assignments of unusual sterol nuclei (e.g. 4␣,14-dimethyl ⌬ 7,9(11) ) were validated by comparisons with published data. Furthermore, 2-D NMR experiments, Fig. 1 . GLC tracings of two distinct sterol profiles found in different Pneumocystis jirovecii specimens. Dashed arrow, cholesterol; solid arrow, pneumocysterol. A. Sample with low levels of late-eluting sterol peaks. Organisms were purified from a cryopreserved Pneumocystis pneumonia (PcP) human lung obtained from a HIV-negative non-Hodgkin lymphoma patient who had been treated with TMP/SMZ. B. Sample with low levels of late eluting components obtained from an AIDS patient who was treated with trimethoprim plus sulfamethoxazole (TMP/SMZ), pentamidine, and steroid. C. Sample with high proportions of late-eluting GLC sterol peaks. Organisms were isolated from a cyropreserved PcP human lung obtained from an AIDS patient who died without receiving treatment for the infection. D. Sample with high proportions of lateeluting peaks. The P. jirovecii 14DM Ϫ -infected formalin-fixed human lung was the source of sterols analyzed by NMR in this report. The lung was from an AIDS patient who died of PcP without receiving treatment for the infection.
i.e. Heteronuclear Multiple Bond Coherence (HMBC) and Correlation Spectroscopy (COSY)) were used for assignment of the dichloro side chain.
Quantitation of individual sterol components. Cholesterol and 4,4-dimethyl sterols were quantified gravimetrically. Total 4␣-methyl sterols and non-cholesterol desmethylsterols were estimated by comparison of the NMR spectra of these fractions with the NMR spectrum of known amounts of a stigmasterol standard by using the residual CHCl 3 solvent peak as reference. The relative proportions of sterols within each category were determined by integration of HPLC peak areas.
RESULTS
Normal human lung controls: GLC analysis. The major sterol in formalin-fixed autopsied P. jirovecii-negative lungs was cholesterol (Table 1) . Other sterols were tentatively identified as lanosterol and desmosterol (precursors of cholesterol in mammals), as well as the plant sterols campesterol and ␤-sitosterol.
Two Pneumocystis jirovecii sterol compositions: GLC analysis. We observed two distinct types of sterol compositions in GLC tracings (Fig. 1) . One type had only low amounts of sterols with RRT chol Ͼ1.6 (Fig. 1A & 1B) . Most sterols in these P. jirovecii specimens were C 27 , C 28 , and C 29 compounds. Other human-derived specimens from PcP patients, including those who received no drug treatment for the infection, also had similar GLC sterol profiles with low pneumocysterol (not shown).
In contrast, the other type (14DM Ϫ ) had high proportions of C 31 -C 32 sterols, notably pneumocysterol ( Fig. 1C and 1D ). Profiles that appear to be intermediate between these two general categories were observed.
Individual sterol molecular species identified in the 14DM Ϫ sample. Twenty-eight different sterols were identified in this sample from the P. jirovecii-infected human lung (Table  2 ; Fig. 2 ). Cholesterol was the major sterol in P. jirovecii. Ergosterol (the major sterol of most fungi) was not detected. The 28 molecular species contained combinations of nine different nuclei and ten different side chains.
Among the sterols that were not identified by our previous NMR analysis of P. carinii sterols , six were known compounds (Fig. 2 : D, G, K, L, M, BB) and eight were novel ( Fig. 2 ; E, F, H, I, N, O, P, AA). Elucidation of the eight novel sterol structures was obtained by a combination of NMR and MS data (Table 3) . Minor products of the second side chain methylation step, such as the novel (24S)-ethyllanosta-8,25-dien-3␤-ol ( Fig. 2 ; E), were also identified among the P. jirovecii sterols. Percent composition of P. jirovecii 14DM Ϫ sterols and putative scavenged sterols. The percents of the total sterols represented by individual components are shown in Fig. 2 . Sterol nuclear structures were compared with those of rat-derived P. carinii for which data had been obtained employing similar TLC and HPLC purification and structural analysis by NMR spectroscopy . There were striking differences in the sterol composition of P. jirovecii 14DM Ϫ ; a paucity of the ⌬ 7 sterols that are typical of Pneumocystis organisms (Furlong et al. 1994; Giner et al. 2002; Kaneshiro and Wyder 2000; Kaneshiro et al 1994; Urbina et al. 1997; Zhou et al. 2002) and an abundance of 14␣-methyl sterols. Fifteen of the 28 P. jirovecii 14DM Ϫ sterols had a methyl group at C-14 of the sterol nucleus and these comprised 96.43% of the total noncholesterol sterols. Non-cholesterol desmethyl sterols (sterols with methyl groups absent at C-4 and C-14) only made up 0.8% of the total mass of sterols in this specimen. Other minor sterol nuclear structures were observed.
24-Alkylsterols. Twenty-four of the 28 sterols were compounds alkylated at the C-24 position of the side chain (Fig. 2) . With the exception of lanosterol ( Fig. 2; A) , the first sterol intermediate formed in the biosynthetic pathway, all P. jirovecii 14DM Ϫ sterols with methyl groups at C-14 and C-4 of the nu- cleus also had an alkyl group at C-24 of the side chain. These results indicate that SAM:SMT in these 14DM
Ϫ organisms is fully functional.
DISCUSSION
Cholesterol was the major sterol in P. jirovecii confirming previous reports on P. jirovecii sterols (Amit and Kaneshiro 2001; Kaneshiro and Wyder 2000; Kaneshiro et al 1999a; Kaneshiro et al. 1996) . The detection of phytosterols in the present study verifies previous reports that these dietary compounds are absorbed and present in human serum and various tissues as well (Glueck et al. 1991; Mellies et al. 1976; Salen et al. 1985; Tammi et al. 2001) . The levels of phytosterols in human tissues (e.g. campesterol, ␤-sitosterol, stigmasterol, and bassicasterol) depend on an individual's diet.
The sterol profiles with low concentrations of components with RRT chol Ͼ 1.6 were similar to those of P. carinii from corticosteroid-immunosuppressed rats (Furlong et al. 1994; Gi- (17), 271(16), 253(15), 145(16), 107(18), 105(21), 97(20), 95(27), 91(17), 83(44), 81(23), 79(15), 69(67), 67(23), 57(25) (23), 253(21), 157(20), 145(24), 111(39), 109(44), 97(63), 95(59), 93(23), 91(17), 83(71), 81(54), 79(17), 69(80), 67(34), 55(100). (24,25) (86), 495(82), 479(21), 477(30), 371(4), 245(7), 201(12), 161(24), 159(26), 147(25), 145(28), 121(45), 119(49), 109(48), 107(57), 105(60), 97(30),95(88), 93(53), 91(50), 83(43), 81(64), 77(22), 69(76), 67(51), 57(42), 55(100) Kaneshiro et al. 1994; Urbina et al. 1997; Zhou et al. 2002) and Pneumocystis isolated from SIV monkeys, weanling rabbits, corticosteroid-immunosuppressed mice, and scid/scid mice (Amit, 1998) . Thus far, sterol profiles with high concentrations of components with RRT chol Ͼ 1.6 have been observed only in some P. jirovecii samples. Sterol compositions that appear to be intermediate between these two general categories were also observed in other P. jirovecii samples; those are believed to result from sterols in mixed populations of these two distinct types of organisms (co-infections) (Amit and Kaneshiro 2001; Kaneshiro et al. 1999a ).
There were 14 compounds that were also earlier reported among the 43 sterols of P. carinii . These were lanost-8,24-dien-3␤-ol (lanosterol), 24-methylenelanost-8-en-3␤-ol (eburicol), (Z)-24-ethylidene-lanost-8-en-3␤-ol (pneumocysterol), (Z)-4,4-dimethyl-stigmasta-8,24(28)-dien-3␤-ol ([24Z]-ethylidene-14-norlanosterol), (Z)-stigmasta-8(14),24(28)-dien-3␤-ol, cholest-7-en-3␤-ol (lathosterol), (Z)-stigmasta-7,24(28)-dien-3␤-ol, cholesterol, ergosta-5,24(28)-dien-3␤-ol, (24S)-ergost-5-en-3␤-ol, (Z)-stigmasta-5,24(28)-dien-3␤-ol (isofucosterol), (24S)-stigmast-5-en-3␤-ol, (24R)-stigmast-5-en-3␤-ol (␤-sitosterol), and (24S)-stigmasta-5,25-dien-3␤-ol (clerosterol), (Fig. 2: A, B , C, J, Q, R, S, T, U, V, W, X, Y, and Z, respectively).
This comprehensive study elucidating definitive structural identities of P. jirovecii 14DM Ϫ sterols indicated that this particular population had essentially no C-14 demethylase activity. The blockage of sterol 14␣-demethylation was especially evident in the 4␣-methyl sterols, all of which contained the 14- Fig. 3 . Postulated normal sterol nucleus metabolism in Pneumocystis. The presence of the methyl group at C-14 hinders the removal of methyl groups at C-4 and the isomerization of the C-8 double bond to C-7. In Pneumocystis carinii normal processing of the sterol nucleus progresses to form the organism's characteristic ␦ 7 desmethyl sterols. These reactions appear to also occur in wild-type P. jirovecii, as indicated in Fig. 1A . In contrast, the consequence of C-14 methyl group retention in P. jirovecii sterol C-14 demethylase-negative (DM Ϫ) is the inhibition of further reactions in the normal metabolism of the sterol nucleus, as indicated in Table 3. methyl group, in striking contrast to the situation in P. carinii and other Pneumocystis species with or without steroid treatment (Amit, 1998; Giner et al. 2002) . Triazole treatment of yeasts and other fungi leads to the accumulation of sterols retaining the 14␣-methyl group (Isaacson et al. 1988; Kato et al. 1975; Maillot-Vernier et al. 1990; Schmitt and Benveniste 1979; Taton et al. 1988 ). The P. jirovecii specimen analyzed in the present study, as well as other specimens containing either high or low percentages of pneumocysterol and other C 31 and C 32 sterols, were obtained from individuals with no record of being treated with azoles or steroids at the time of death or sampling (Amit 1998; Amit and Kaneshiro 2001; Kaneshiro et al. 1999a) . Thus, azole inhibition of P. jirovecii 14DM cannot explain the 14DM Ϫ sterol composition phenotype. Recently, Morales et al. (2003) demonstrated that the P. carinii 14DM was functional by inserting the P. carinii erg11 gene into a S. cerevisiae erg11 deletion mutant. They identified two sites that were identical to those in a fluconazole-resistant strain of C. albicans and they altered the P. carinii erg11 gene by site-directed mutagenesis at these two loci to those in the azolesensitive Candida. The sites altered were E113 to D and T125 to K. The S. cerevisiae expressing the P. carinii erg11 gene or the mutated gene were tested against three azole antifungal drugs. Higher concentrations of fluconazole and voriconazole were required to inhibit growth of yeast expressing the P. carinii erg11 or the mutated erg11 genes compared to yeast containing the S. cerevisiae erg11 gene. On the other hand, itraconazole was a potent inhibitor of growth of S. cerevisiae expressing either the P. carinii erg11 gene or the mutated gene. However, it should be noted that D116E and D128T mutations are also found in azole-sensitive strains of C. albicans (Marichal et al. 1999) , thus the importance of these amino acid substitutions in azole binding and susceptibility to fluconazole in P. carinii remains an open question. Studies on azole sensitivity of a native or recombinant Pneumocystis 14DM by direct enzyme analysis have yet to be reported.
A possible explanation for the observations made in the present study is that P. jirovecii DM Ϫ organisms resulted from mutations in organisms exposed to antimycotic drugs (Sanglard et al. 2003; Walsh and Sisler 1982) . It is well known that both azole antifungal agents (imidazole and triazole derivatives) (Bartlett et al. 1994) and amphotericin B are ineffective in clearing PcP but these drugs are commonly used worldwide for a number of fungal, protozoan, and other parasitic infections. Interestingly, it was recently reported that C. albicans exposed to amphotericin B in vitro gave rise to erg11/erg11 mutants with amphotericin B and azole drug resistance, and these cells accumulated high percentages of sterols containing the C-14 methyl group (Sanglard et al. 2003) . If P. jirovecii erg11 mutants had similarly been produced by exposure to amphotericin B, proliferation and transmission of the mutants could become broadly distributed. This sterol composition phenotype appears to have spread among human populations, as suggested by the common occurrence of high pneumocysterol in many P. jirovecii specimens (Amit 1998) . It is also possible that several different putative erg11 mutants developed independently, as the 14DM Ϫ sterol profile has been detected in P. jirovecii specimens from both the USA and Europe (Amit 1998; Kaneshiro et al. 1999a ). The rapid expression and high incidence of 14DM Ϫ phenotype populations is consistent with the haploid nature of intrapulmonary Pneumocystis organisms (Wyder et al. 1988) . Thus, the observed sterol composition is most simply explained by a mutation in the 14DM gene as most organisms known to produce sterols normally have 14DM in their biosynthetic pathways. The sterols of putative wild-type P. jirovecii with active 14DM have yet to be analyzed by NMR. However, until detailed genetic analysis of the P. jirovecii erg11 genes from wild type and putative mutant organisms have been examined, it cannot be ruled out that other factors regulating gene expression or enzyme activity are responsible. It also cannot be ruled out that the two types of sterol composition phenotypes reflect distinct species of Pneumocystis. It is known that there is heterogeneity in the genetic make-up of Pneumocystis infecting humans and some patients are apparently infected with a single genotype or co-infected with organisms of diverse genotypes (Hauser et al. 2001; Helweg-Larsen et al. 2001) . However, criteria for assigning taxonomically distinct Pneumocystis species infecting humans have not yet been fulfilled. There is no Pneumocystis from any mammalian host species that has been cloned and placed under conditions supporting indefinite subculturing of organisms. Pneumocystis carinii and P. wakefieldii were grown in immunosuppressed laboratory rats, which enabled various analyses to be performed to establish these as two separate species (Cushion et al. 2004) . Infecting immunodeficient humans with P. jirovecii is not an experimental option.
The data on the P. jirovecii 14DM Ϫ sterols strongly support the predicted series of reactions in Pneumocystis sterol nucleus metabolism (Fig. 3) , which is in agreement with what is known in other organisms (Isaacson et al. 1988; Kato et al. 1975; Maillot-Vernier et al. 1990; Schmitt and Benveniste 1979; Taton et al. 1988) . In yeasts and some other fungi lanosterol is the preferred substrate for SAM:SMT. The product 24-methylenelanosterol (eburicol) is then the substrate for 14DM (Mercer 1984) . On the other hand, in Saccharomyces cerevisiae and some Candida albicans isolates, eburicol has not been detected and it is believed that the biosynthesis of sterols from lanosterol involves the sequence of demethylation at the C-4 position, demethylation at C-14 position, and then demethylation at the 4␣-position (Daum et al. 1998; Hitchcock et al. 1989; Parks et al. 1995) . In these P. jirovecii 14DM Ϫ organisms, removal of a methyl group at C-4 has occurred in some molecules, but due to the lack of 14DM activity, subsequent modifications of the sterol nucleus appear to be blocked. As only very low levels of ⌬ 7 sterols were present, this suggested that the ⌬ 8 -to-⌬ 7 isomerase activity is blocked by the presence of the C-14 methyl group. The structural nature and quantities of the sterols are consistent with a block in activity of the enzyme 14␣-demethylase in this P. jirovecii population.
The ⌬ 5 nucleus (e.g. of cholesterol) could represent (1) sterols present in the human lung but not in the P. jirovecii organisms, (2) sterols present in the lung and taken up by P. jirovecii, or (3) sterols present in the lung taken up by P. jirovecii and subsequently metabolized by the fungus, especially by the action of SAM:SMT. As in purified rat-derived P. carinii in which most if not all cholesterol is scavenged by the organism (Worsham et al. 2003) , we currently interpret cholesterol in this P. jirovecii specimen as coming from cholesterol in the human lung tissue plus cholesterol taken up by the organisms. The ⌬ 7 24-alkylsterols produced by Pneumocystis are characterized by the ␤ configuration of the group at C-24 of the sterol side chain (Fig. 4) . Based on the stereochemistry of the ⌬ 5 24-alkylsterol ␤-sitosterol ( Fig. 2 ; Y) and its presence in uninfected human lung controls, this sterol is interpreted as originating from dietary plant material, which was absorbed and then translocated into the lung alveolar lining where the organisms proliferated. Other ␦ 5 24-alkylsterols identified, such as methylenecholesterol (Fig. 2, U ) and isofucosterol ( Fig. 2; W) , might have been produced by Pneumocystis SAM:SMT action on desmosterol synthesized by the mammalian host and scavenged by the organism (Giner 1993) .
Sterol biosynthetic reactions are attractive targets for developing new therapies against PcP; SAM:SMT and lanosterol synthase are enzymes that appear to be good candidates (Hinshaw et al. 2003; Kaneshiro et al. 2002; Urbina et al. 1997) . 14DM may be a target for clearing PcP caused by Pneumocystis with active enzyme, but our discovery of P. jirovecii populations lacking 14DM activity provides valuable information for the development of chemotherapeutic approaches to manage PcP. Although drugs such as fluconazole are not effective against P. carinii with active 14DM, other compounds targeting this enzyme show promise as anti-Pneumocystis agents . However, it is doubtful that drugs designed to inhibit P. jirovecii 14DM would be able to clear these putative 14DM
Ϫ populations present among human populations in North America and Europe.
